You are here: Industry Insights > 2024

News List

Which ADCs Are Favored by Global Companies in 2024? 2 Bispecific ADCs, 5 Transactions Exceeding USD 1 Billion Yi
January 23, 2025
ADCs are a hot drug R&D area, with 16 global approvals and a >$10B 2023 market. Chinese firms shine, 2 products approved, 11 out-licensing deals in 2024, 5 over $1B, boosting ADC internationalization.
A Record High! A Review of Blockbuster New Drugs in China in 2024, with the Number of Innovative Drugs Reaching New Heights! Sophia
January 23, 2025
In 2024, China's pharmaceutical field thrived. NMPA approved 220 new drugs, including 46 Class 1 innovative ones with anti-tumor drugs being the most. New anti-tumor drugs offered hope, and the R&D environment will keep improving.
New FDA Regulations in the Year 2024 Muhammad Asim Niazi
January 07, 2025
The United States FDA regulates pharma drug products manufactured or marketed in the United States. There are many different functions of the FDA, and one of them is devising new regulations.
Popular Products and Companies at PharmaSources.com (June 2024) PharmaSources
June 25, 2024
Popular Products and Companies at PharmaSources.com
Pharma Sources Insight June 2024: Globalization on the GO! Pharma Sources Insight
June 29, 2024
Pharma Sources Insight JUNE 2024 focuses on wearable delivery system, sythetic biology, pharmaceutical globalization and more.
2024 Medical Breakthroughs: New Hope to Patients Shruti Talashi
April 11, 2024
The pharmaceutical industry is set for a major shake-up in 2024.
Popular Products and Companies at PharmaSources.com (January 2024) PharmaSources
February 23, 2024
Popular Products and Companies at PharmaSources.com
Pharma Sources Insight January 2024: Pharmaceutical Industry in 2024 - Flexible Production, Innovative Drugs and Personalized Medicine Pharma Sources Insight
January 15, 2024
Pharmaceutical Industry Outlook in 2024.
What To Expect in the 2024 Pharmaceutical Market Suzanne Elvidge
January 12, 2024
The pharmaceutical market is growing fast. According to Statista.The largest market is oncology, predicted to be worth US$214.10 billion in 2024.
InnoCare Releases 2024 Results and Business Highlights PharmaSources
March 27, 2025
InnoCare announced 2024 annual results, including financials, R&D progress in oncology and autoimmune diseases, and globalization efforts.